Last updated on July 2020

Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)


Brief description of study

Primary Objective:

To evaluate the long-term safety and tolerability of dupilumab in pediatric patients with asthma who participated in a previous dupilumab asthma clinical study.

Secondary Objectives:

  • To evaluate the long-term efficacy of dupilumab in pediatric patients with asthma who participated in a previous dupilumab asthma clinical study.
  • To evaluate dupilumab in pediatric patients with asthma who participated in a previous dupilumab asthma clinical study with regard to:
  • Systemic exposure.
  • Anti-drug antibodies (ADAs).
  • Biomarkers.

Detailed Study Description

Study duration per participant is approximatively 64 weeks including a 52 weeks treatment period and 12 weeks post treatment follow-up.

Clinical Study Identifier: NCT03560466

Find a site near you

Start Over

Investigational Site Number 8400001

Rolling Hills Estates, CA United States
  Connect »

Investigational Site Number 6430003

Saint-Petersburg, Russian Federation
  Connect »

Investigational Site Number 6430002

Saint Petersburg, Russian Federation
  Connect »

Investigational Site Number 6430005

St Petersburg, Russian Federation
  Connect »

Investigational Site Number 6430001

Saint-Petersburg, Russian Federation
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.